Hotline update of clinical trials and registries presented at the ACC and SCAI-ACCi2 meeting 2008 in Chicago

Clinical Research in Cardiology

Volumn 97, Issue 7, 2008, Pages 409-417

  Clever, Yvonne P ^a   Rosenkranz, Stephan ^a,b   Böhm, Michael ^a   Scheller, Bruno ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

ACCOMPLISH; ARMYDA RELOAD; BRAVE 3; CONTRAST; ENHANCE; HYVET; ISAR REACT 3; MAIN COMPARE; ONTARGET; PEPCAD II; PERISCOPE; SPIRIT II; STRADIVARIUS; TRANSFER AMI; TRITON TIMI 38

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; AMLODIPINE; BENAZEPRIL; CLOPIDOGREL; ENOXAPARIN; EVEROLIMUS; EZETIMIBE PLUS SIMVASTATIN; GLIMEPIRIDE; HEPARIN; HIRULOG; HYDROCHLOROTHIAZIDE; INDAPAMIDE; IODIXANOL; IOMEPROL; ORAL ANTIDIABETIC AGENT; PACLITAXEL; PERINDOPRIL; PIOGLITAZONE; PLACEBO; PRASUGREL; RAMIPRIL; RIMONABANT; SIMVASTATIN; TELMISARTAN; TENECTEPLASE;

ABDOMINAL OBESITY; ANGINA PECTORIS; ANGIONEUROTIC EDEMA; ATHEROGENESIS; ATHEROSCLEROSIS; BLEEDING; BLOOD CLOT LYSIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CONTRAST MEDIUM INDUCED NEPHROPATHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; COUGHING; DIABETES MELLITUS; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG INDUCED DISEASE; DRUG INDUCED NEPHROPATHY; DRUG SAFETY; EDEMA; ERECTILE DYSFUNCTION; FAMILIAL HYPERCHOLESTEROLEMIA; FRACTURE; HEART INFARCTION; HUMAN; HYPOGLYCEMIA; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LOADING DRUG DOSE; MENTAL DISEASE; MONOTHERAPY; NAUSEA; PERCUTANEOUS CORONARY INTERVENTION; SIDE EFFECT; ST SEGMENT ELEVATION; SYNCOPE; SYSTOLIC HYPERTENSION; THROMBOCYTOPENIA; TRANSLUMINAL CORONARY ANGIOPLASTY; WEIGHT GAIN;

CARDIOLOGY; CARDIOVASCULAR DISEASES; CHICAGO; CLINICAL TRIALS AS TOPIC; HOTLINES; META-ANALYSIS AS TOPIC; REGISTRIES; SOCIETIES, MEDICAL;

EID: 47549085918     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-008-0672-7     Document Type: Conference Paper

References (26)

1. Beckett NS, Peters R, Fletcher AE et al; HYVET Study Group (2008) Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358:1887-1898
2. GG Biondi-Zoccai M Lotrionte C Moretti E Meliga P Agostoni M Valgimigli A Migliorini D Antoniucci D Carrié G Sangiorgi A Chieffo A Colombo MJ Price PS Teirstein EH Christiansen A Abbate L Testa JP Gunn F Burzotta A Laudito GP Trevi I Sheiban 2008 A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease Am Heart J 155 2 274 283 Epub 2007 Nov 26 review
3. CJ Bulpitt NS Beckett J Cooke 2003 Results of the pilot study for the hypertension in the Very Elderly Trial J Hypertens 21 2409 2417
4. Cantor WJ, Fitchett D, Borgundvaag B et al (2008) For the TRANSFER-AMI investigators. Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI annual meeting. Late breaking clinical trials. Chicago, 29 March-1 April
5. AV Chobanian GL Bakris HR Black 2003 Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 42 1206 1252
6. DiSciascio G, Patti G, Colonna G et al (2008) Clopidogrel reloading before percutaneous coronary intervention improves outcome in patients with acute coronary syndromes receiving chronic clopidogrel therapy. Results of the antiplatelet therapy for reduction of myocardial damage during angioplasty-RELOAD (ARMYDA-RELOAD) randomized trial. In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI annual meeting. Late breaking clinical trials. Chicago, 29 March-1 April
7. JA Dormandy B Charbonnel DJA Eckland 2005 for the PROACTIVE Investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial macroVascular Events): a randomized controlled trial Lancet 366 1279 1289
8. EB Friedrich KK Teo M Böhm 2006 ACE inhibition in secondary prevention: are the results controversial? Clin Res Cardiol 95 61 67
9. F Gueyffier C Bulpitt JP Boissel 1999 Antihypertensive drugs in very old people: a subgroup meta-analysis of randomized controlled trials. INDANA Group 1 Lancet 353 793 796
10. Jamerson KA, Weber MA, Bakris GL, Dahlöf B, Pitt B, Velazquez E, on behalf of the ACCOMPLISH Investigators (2008) Avoiding cardiovascular events through combination therapy in patients living with systolic hypertension. American College of Cardiology Scientific Sessions. Chicago, 31 March
11. JJ Kastelein F Akdim Es Stroes 2008 For the ENHANCE investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia N Engl J Med 358 1431 1443
12. Kastrati A, Neumann FJ, Mehilli J et al (2008) A randomized, double-blind, active-controlled, multi-center trial (ISAR-REACT 3) of bivalirudin versus unfractionated heparin in troponin-negative patients undergoing percutaneous coronary interventions after pre-treatment with 600 mg of clopidogrel. In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI annual meeting. Late breaking clinical trials. Chicago, 29 March-1 April
13. G Mancia G de Backer A Dominiczak 2007 For the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Guidelines for the management of arterial hypertension Eur Heart J 28 1462 1536
14. Mehilli J, Kastrati A, Huber K et al (2008) Pretreatment with a high loading dose of clopidogrel and value of abciximab during primary coronary intervention in patients with acute myocardial infarction. Results of the randomized BRAVE-3 trial. In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI annual meeting. Late breaking clinical trials. Chicago, 29 March-1 April
15. SE Nissen SJ Nicholls K Wolski 2008 For the PERISCOPE investigators. Comparison of pioglitazone vs. glimepiride on progression of coronary atherosclerosis in pa-tients with type 2 diabetes JAMA 299 1561 1573
16. SE Nissen SJ Nicholls K Wolski 2008 For the STRADIVARIUS investigators. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease. The STRADIVARIUS randomized controlled trial JAMA 299 1547 1560
17. Scheller B, Hehrlein C, Bocksch W, Rutsch et al (2006) Treatment of in-stent restenosis with a paclitaxel-coated balloon catheter. New Engl J Med 355:2113-2124 (Epub 2006 Nov 13)
18. B Scheller B Hennen B Hammer J Walle C Hofer V Hilpert H Winter G Nickenig M Böhm for the SIAM III Study Group 2003 Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction J Am Coll Cardiol 42 634 641
19. Serruys PW (2008) On behalf of the SPIRIT II Investigators. SPIRIT II study: a clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions. In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI annual meeting. Late breaking clinical trials. Chicago, 29 March-1 April
20. Seung KB, Park DW, Kim YH et al (2008) Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 358:1781-1792
21. B Staels JC Fruchart 2005 Therapeutic roles of peroxisome proliferators-activated receptor agonists Diabetes 54 2460 2470
22. G Tepe T Zeller T Albrecht 2008 Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg New Engl J Med 358 689 699
23. The ONTARGET investigators 2008 Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med 358 1547 1559
24. Unverdorben M, Degenhardt R, Vallbracht C et al (2008) Paclitaxel-eluting devices: randomized comparison of the SeQuent® please balloon catheter versus the Taxus® stent in the treatment of in-stent-restenosis-12-month follow-up of the PEPCAD II ISR study. In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI annual meeting. Late breaking clinical trials. Chicago, 29 March-1 April
25. Wessely R, Koppara T, Kastrati A et al (2008) Randomized clinical trial to compare the nephrotoxic effects of iso-osmolar versus low-osmolar contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention: the COntrast Media and NephroToxicity Following Coronary Revascularization by AngioplaSTy (CONTRAST) study. In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI Annual meeting. Late breaking clinical trials. Chicago, 29 March-1April
26. Wiviott SD, Braunwald E, McCabe CH et al; TRITON-TIMI 38 Investigators (2008) Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet 371:1353-1363